The Department of Health and Social Care (DHSC) has today (20/09/2022) granted the following initial list of price concessions:
Alendronic acid 70mg tablets
Amisulpride 100mg tablets
Amisulpride 200mg tablets
Amisulpride 50mg tablets
Amorolfine 5% medicated nail lacquer
Amoxicillin 250mg/5ml oral suspension
Amoxicillin 250mg/5ml oral suspension sugar free
Bimatoprost 100micrograms/ml eye drops
Bisacodyl 5mg gastro-resistant tablets
Brimonidine 0.2% eye drops
Chlorpromazine 100mg tablets
Chlorpromazine 25mg tablets
Chlorpromazine 50mg tablets
Clarithromycin 250mg/5ml oral suspension
Dipyridamole 100mg tablets
Duloxetine 30mg gastro-resistant capsules
Duloxetine 60mg gastro-resistant capsules
Escitalopram 10mg tablets
Escitalopram 5mg tablets
Temazepam 10mg tablets
PSNC is seeking improvements to the current price concessions system following significant concerns raised by pharmacy contractors about the unsustainable level of prices, imposed by DHSC in the past few months, for certain medicines. To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of PSNC’s recent webinar here.
No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.
PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated September 2022 Drug Tariff price. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.
If you have problems obtaining a Part VIII product at the stated Drug Tariff price, please report the issue using the online feedback form on the PSNC website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Contractors will be alerted to further updates to the price concession list through our website and via our e-news email. If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made.